AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

eFFECTOR Therapeutics, Inc.

$0 +$0.00 (+300.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.01
Market Cap
3.76K
AVG Volume
2.76K
Trailing/Forward PE
-0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-17
Primary Exchange
Other OTCUS
Revenue (USD)
01M2M3M21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR Revenue (USD) by quarter
PeriodRevenue (USD)
24 Q10
23 Q4162K
23 Q30
23 Q20
23 Q10
22 Q40
22 Q30
22 Q22.01M
22 Q10
21 Q41.43M
Net Income (USD)
-20M-10M010M20M21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR Net Income (USD) by quarter
PeriodNet Income (USD)
24 Q1-8.83M
23 Q4-9.13M
23 Q3-8.3M
23 Q2-8.36M
23 Q1-10.01M
22 Q4-9.26M
22 Q3-9.56M
22 Q2-6.92M
22 Q13.07M
21 Q419.05M
Operating Income (USD)
-10M010M20M30M21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR Operating Income (USD) by quarter
PeriodOperating Income (USD)
24 Q1-8.4M
23 Q4-8.6M
23 Q3-8.3M
23 Q2-7.86M
23 Q1-9.54M
22 Q4-8.72M
22 Q3-9.25M
22 Q2-7.88M
22 Q1-6.55M
21 Q420.03M
EBITDA (USD)
-15M-10M-5M05M21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR EBITDA (USD) by quarter
PeriodEBITDA (USD)
24 Q1-8.06M
23 Q4-8.34M
23 Q3-7.83M
23 Q2-7.62M
23 Q1-9.3M
22 Q4-8.54M
22 Q3-8.97M
22 Q2-6.41M
22 Q13.55M
21 Q4-12.4M
Cash Flows (USD)
-10M-7.5M-5M-2.5M021 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR Cash Flows (USD) by quarter
PeriodCash Flows (USD)
24 Q1-7.28M
23 Q4-5.62M
23 Q3-7.76M
23 Q2-8.62M
23 Q1-7.65M
22 Q4-6.79M
22 Q3-8.23M
22 Q2-4.51M
22 Q1-6.55M
21 Q4-5.04M
EPS (USD)
-10-505101521 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR EPS (USD) by quarter
PeriodEPS (USD)
24 Q1-3.31
23 Q4-3.42
23 Q3-3.36
23 Q2-4.37
23 Q1-5.96
22 Q4-5.57
22 Q3-5.8
22 Q2-4.2
22 Q11.77
21 Q411.79
Expenses (USD)
05M10M15MR&DSG&ACapex21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR Expenses (USD) by quarter
PeriodExpenses (USD)
24 Q18.4M
23 Q48.62M
23 Q37.86M
23 Q27.88M
23 Q19.55M
22 Q49.41M
22 Q310.16M
22 Q29.97M
22 Q16.61M
21 Q412.75M
Cash & Debt (USD)
020M40M60MCashLong Term DebtShort Term Debt21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
24 Q125.38M
23 Q418.37M
23 Q317.78M
23 Q225.02M
23 Q119.01M
22 Q426.31M
22 Q332.96M
22 Q241.04M
22 Q145.71M
21 Q449.7M
Debt ratios
-2024621 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR Debt ratios by quarter
PeriodDebt ratios
24 Q10.16
23 Q4-0.07
23 Q3-0.08
23 Q20.13
23 Q1-0.04
22 Q40.3
22 Q30.53
22 Q23.55
22 Q15.68
21 Q42.07
Margins
-15000%-10000%-5000%0%5000%20 Q120 Q220 Q320 Q421 Q221 Q321 Q422 Q223 Q4
EFTR Margins by quarter
PeriodMargins
23 Q481.48%
22 Q299.85%
21 Q499.72%
21 Q398.59%
21 Q2-488.44%
20 Q4-10854.76%
20 Q3-1081.18%
20 Q267.94%
20 Q178.64%
Return on Capital
-1500%-1000%-500%0%500%21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR Return on Capital by quarter
PeriodReturn on Capital
24 Q1-1068.2%
23 Q4157.53%
23 Q3209.35%
23 Q2-324.82%
23 Q1208.06%
22 Q4-237.68%
22 Q3-82.69%
22 Q2-35.24%
22 Q112.16%
21 Q4110.21%
Shares Outstanding
01M2M3M21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR Shares Outstanding by quarter
PeriodShares Outstanding
24 Q12.67M
23 Q42.67M
23 Q32.47M
23 Q21.91M
23 Q11.68M
22 Q41.66M
22 Q31.65M
22 Q21.64M
22 Q11.74M
21 Q41.62M
Book Value Per Share (USD)
-505101521 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
24 Q10.31
23 Q4-2.17
23 Q3-1.61
23 Q21.35
23 Q1-2.86
22 Q42.34
22 Q37.02
22 Q211.93
22 Q114.54
21 Q410.7
Total Assets (USD)
020M40M60M21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q1
EFTR Total Assets (USD) by quarter
PeriodTotal Assets (USD)
24 Q127.13M
23 Q420.54M
23 Q320.16M
23 Q226.89M
23 Q121.93M
22 Q429.08M
22 Q336.65M
22 Q243.47M
22 Q149.49M
21 Q454.06M
Employee Count
0510152020202120222023
EFTR Employee Count by quarter
PeriodEmployee Count
202314
202215
202113
20202
PE Ratio
02505007501000med 3.23May 21Apr 22Jun 22Aug 22Oct 22Dec 22Mar 23
EFTR PE Ratio by quarter
PeriodPE Ratio
Mar 233.86
Feb 233.52
Feb 234.48
Feb 234.27
Feb 234.84
Jan 233.71
Jan 233.42
Jan 233.28
Jan 233.65
Dec 223.12
Dec 223.06
Dec 222.95
Dec 223.07
Dec 223.2
Nov 223.43
Nov 223.79
Nov 223.94
Nov 220.9
Oct 221.06
Oct 221.01
Oct 221
Oct 221.08
Sep 220.98
Sep 220.96
Sep 221.04
Sep 221.1
Sep 220.85
Aug 221.07
Aug 221.08
Aug 221.28
Aug 221.4
Jul 221.38
Jul 221.5
Jul 221.91
Jul 222.39
Jul 222.23
Jun 222.59
Jun 222.54
Jun 222.79
Jun 223.05
May 223.27
May 222.92
May 223.07
May 226.89
Apr 228.51
Apr 228.49
Apr 229
Apr 229.82
Apr 229.77
Mar 2210.58
Mar 2212.99
May 21885.22
May 21878.91
May 21876.2
May 21882.51
Apr 21883.42
Apr 21883.42
Apr 21896.94
Apr 21896.94
Apr 21887.92
Free Cash Flow Yield
-15000000%-10000000%-5000000%0%med -5482291.87%Jan 25May 25Sep 25Jan 26May 26Sep 26
EFTR Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1370573%
Sep 26-1370573%
Aug 26-3654861.08%
Aug 26-3654861.25%
Aug 26-5482291.87%
Aug 26-5482292.01%
Jul 26-5482292.01%
Jul 26-1370572.97%
Jul 26-1827430.54%
Jul 26-1827430.54%
Jul 26-1827430.54%
Jun 26-1827430.62%
Jun 26-5482291.87%
Jun 26-5482292.01%
Jun 26-5482291.87%
May 26-1827430.62%
May 26-2192916.64%
May 26-2192916.64%
May 26-2192916.75%
May 26-5482291.87%
Apr 26-5482292.01%
Apr 26-5482291.87%
Apr 26-5482291.87%
Apr 26-5482292.01%
Mar 26-5482292.01%
Mar 26-5482292.01%
Mar 26-5482292.01%
Mar 26-5482292.01%
Feb 26-5482291.87%
Feb 26-5482292.01%
Feb 26-5482291.87%
Feb 26-5482292.01%
Jan 26-5482292.01%
Jan 26-5455016.79%
Jan 26-5482291.87%
Jan 26-5482292.01%
Jan 26-5482292.01%
Dec 25-5482291.87%
Dec 25-5482291.87%
Dec 25-5482291.87%
Dec 25-5482292.01%
Nov 25-5482291.87%
Nov 25-1827430.62%
Nov 25-1827430.54%
Nov 25-1827430.62%
Oct 25-5482292.01%
Oct 25-5482291.87%
Oct 25-5482291.87%
Oct 25-5482292.01%
Oct 25-5482292.01%
Sep 25-5482292.01%
Sep 25-5482291.87%
Sep 25-5482291.87%
Sep 25-5482292.01%
Aug 25-5482292.01%
Aug 25-5482292.01%
Aug 25-5482291.87%
Aug 25-5482291.87%
Aug 25-5482291.87%
Jul 25-5482292.01%
Jul 25-5482292.01%
Jul 25-5482291.87%
Jul 25-5482291.87%
Jun 25-3654861.08%
Jun 25-3654861.08%
Jun 25-3654861.08%
Jun 25-5482292.01%
May 25-5482292.01%
May 25-5482292.01%
May 25-1827430.54%
May 25-5482292.01%
May 25-5482292.01%
Apr 25-5482292.01%
Apr 25-5482292.01%
Apr 25-5482292.01%
Apr 25-5482292.01%
Mar 25-5482292.01%
Mar 25-1827430.54%
Mar 25-1827430.54%
Mar 25-5482292.01%
Feb 25-5482292.01%
Feb 25-5482292.01%
Feb 25-5482292.01%
Feb 25-5482291.87%
Jan 25-5482291.87%
Jan 25-5482292.01%
Jan 25-5482291.87%
Jan 25-5482292.01%
Jan 25-5482291.87%
Dec 24-5482291.87%
Dec 24-5482291.87%
Dec 24-5482291.87%
Dec 24-5482291.87%
Nov 24-5482291.87%
Nov 24-5482291.87%
Nov 24-5482291.87%
Nov 24-5482291.87%
Nov 24-2741145.93%
Oct 24-10964583.74%
Oct 24-913715.31%
Price to Sales
00.010.010.010.02med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EFTR Price to Sales by quarter
PeriodPrice to Sales
Sep 260.01
Sep 260.01
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260.01
Jul 260.01
Jul 260.01
Jul 260.01
Jun 260.01
Jun 260
Jun 260
Jun 260
May 260.01
May 260.01
May 260.01
May 260.01
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250.01
Nov 250.01
Nov 250.01
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250.01
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250.01
Mar 250.01
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240.01
Oct 240
Oct 240.02
EV/EBITDA
8.999.19.2med 8.99Apr 21Apr 21Apr 21May 21May 21
EFTR EV/EBITDA by quarter
PeriodEV/EBITDA
May 219.01
May 218.95
May 218.92
May 218.98
Apr 218.99
Apr 218.99
Apr 219.13
Apr 219.13
Apr 219.04
Price/Operating Cashflow
10.510.610.710.8med 10.6Apr 21Apr 21Apr 21May 21May 21
EFTR Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
May 2110.62
May 2110.55
May 2110.51
May 2110.59
Apr 2110.6
Apr 2110.6
Apr 2110.76
Apr 2110.76
Apr 2110.65
Price to Book
00000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EFTR Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
eFFECTOR Therapeutics, Inc.
EFTR
Stockpicker

Video analysis: EFTR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.